171P Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy

Triple Negative ◽

Early Stage ◽

Breast Cancer Patients ◽

Abstract P4-12-09: Improvement of survival with radiation therapy in early stage triple negative breast cancer patients with high level of tumor infiltrating lymphocytes

10.1158/1538-7445.sabcs19-p4-12-09 ◽

2020 ◽

Author(s):

Jason Aboudi Mouabbi ◽

Momal Chand ◽

Ramen Sakhi ◽

Daniel Ockner ◽

Susan Szpunar ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Triple Negative ◽

Early Stage ◽

Breast Cancer Patients ◽

High Level ◽

High PD-L1 Expression Is Closely Associated With Tumor-Infiltrating Lymphocytes and Leads to Good Clinical Outcomes in Chinese Triple Negative Breast Cancer Patients

International Journal of Biological Sciences ◽

10.7150/ijbs.20868 ◽

2017 ◽

Vol 13 (9) ◽

pp. 1172-1179 ◽

Cited By ~ 12

Author(s):

NiJiati AiErken ◽

Hui-juan Shi ◽

Yu Zhou ◽

Nan Shao ◽

Jin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Triple Negative ◽

Breast Cancer Patients ◽

Abstract OT-13-10: Global Phase 3 Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy

10.1158/1538-7445.sabcs20-ot-13-10 ◽

2021 ◽

Author(s):

Hope Rugo ◽

Louis W.C. Chow ◽

Javier Cortes ◽

Peter A. Fasching ◽

Xu-Bing He ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative ◽

Early Stage ◽

Placebo Treatment ◽

Breast Cancer Patients ◽

Phase 3

Abstract P2-07-02: Tumor infiltrating lymphocytes density and coding mutations effects on the outcome of operable triple negative breast cancer patients

10.1158/1538-7445.sabcs15-p2-07-02 ◽

2016 ◽

Author(s):

V Kotoula ◽

E Fountzilas ◽

K Chatzopoulos ◽

Z Alexopoulou ◽

E Timotheadou ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Abstract P1-10-14: Focus on tumor infiltrating lymphocytes (TIL’s): High levels of spatially positioned CD3 and CD8 cells and high immunoscores are significantly associated with pathological complete responses in triple-negative breast cancer patients

10.1158/1538-7445.sabcs19-p1-10-14 ◽

2020 ◽

Author(s):

Bernardo Leon Rapoport ◽

Simon Nayler ◽

Jerome Galon ◽

B Mlecnik ◽

Teresa Smit ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Cd8 Cells ◽

Prediction Role of Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients Received the Neoadjuvant Chemotherapy: A Meta-Analysis

Chemotherapy Open access ◽

10.4172/2167-7700.1000245 ◽

2017 ◽

Vol 06 (04) ◽

Author(s):

Long Tao Tan ◽

Jian Liu ◽

Kai Cheng ◽

Xiao Hong Wang ◽

Ying Zhe Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative ◽

Meta Analysis ◽

Breast Cancer Patients ◽

Abstract P4-04-06: Immune balance between tumor-infiltrating lymphocytes and tumor-associated macrophages impacts the outcome of triple negative breast cancer patients

10.1158/1538-7445.sabcs15-p4-04-06 ◽

2016 ◽

Cited By ~ 1

Author(s):

G Bottai ◽

C Raschioni ◽

A Losurdo ◽

L Di Tommaso ◽

M Roncalli ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Tumor Associated Macrophages ◽

Immune Balance ◽

Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes

Virchows Archiv ◽

10.1007/s00428-017-2083-5 ◽

2017 ◽

Vol 470 (4) ◽

pp. 381-389 ◽

Cited By ~ 12

Author(s):

Joo Young Kim ◽

Sun-Hee Heo ◽

Seul Ki Choi ◽

In Hye Song ◽

In Ah Park ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Poor Prognostic Factor ◽

High Level ◽

Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05513-4 ◽

2019 ◽

Vol 179 (3) ◽

pp. 533-542 ◽

Cited By ~ 4

Author(s):

Yan Li ◽

Yidong Zhou ◽

Feng Mao ◽

Yan Lin ◽

Xiaohui Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Triple Negative ◽

Early Stage ◽

Meta Analysis ◽

Breast Cancer Patients ◽

Standard Chemotherapy

Prognostic significance of tumor-infiltrating lymphocytes (TILs) in patients with early-stage triple-negative breast cancer (TNBC) treated with curative resection alone

Annals of Oncology ◽

10.1093/annonc/mdx655.014 ◽

2017 ◽

Vol 28 ◽

pp. x19-x20 ◽

Cited By ~ 1

Author(s):

J.H. Park ◽

H.J. Lee ◽

J-H Ahn ◽

J.E. Kim ◽

K.H. Jung ◽

...

Keyword(s):

Breast Cancer ◽

Curative Resection ◽

Triple Negative ◽

Early Stage ◽

Prognostic Significance ◽